WWW.KONF.X-PDF.RU
- , ,
 


Pages:     | 1 |   ...   | 2 | 3 || 5 |

- , BRCA1/2 ...

-- [ 4 ] --

34., .. : ?/ .. [ .] // . 2009. . 3. 4(12). .

48-56.

35., .. : . . - . : 14.03.09 / . , 2013. 30 .

36., .. : / ..

// . 2004. 3(2). . 16-22.

37., .. / .. // . 2013. .13. 3. .18-41.

38., .. - : . . . . :

03.00.15 / . ., 2008. 15 .

39. 2011 / .

.. , .. , .. . 2012, .: . .. , 240 .

40. 2012 / .

.. , .. , .. . 2013, .: . .. , 232 .

41. 2009 / . . . , . . // .

. . . 2011. 22. 3(85). 172 .

42., A.P. / .. , .. , ..

, .. // . 2003. 24(3). . 184, .. : . . - . : 14.00.14 / . ., 2002. 48 .

44., .. - : . . . . : 03.02.07 / . , 2012. 24 .

45., .. : . . . . :

14.00.27 / . ., 2009. 19 .

46., .. BRCA1 BRCA2 / ..

[ .] // . 2010. 5(41). . 32-35.

47., .. - BRCA1/2 : .

. . . : 03.02.07 / . ., 2011. 24 .

48., .. / .. // . 1997. 5. . 7-14.

49.Abdolrahim-Zadeh, H. Interleukin-10 promoter polymorphisms and breast cancer risk in Iranian women / H. Abdolrahim-Zadeh [et al.] // Iranian Journal of Immunology. 2005. 2(3). P.158-165.

50.Afzali, B. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease / B. Afzali [et al.] // Clinical and Experimental Immunology. 2007. 148. P. 32-46.

51.Althwani, A. The role of interleukin-10 in women with metastatic invasive ductal carcinoma / A. Althwani, M. Najm // Fac Med Baghdad. 2011. 53(3). .

289-292.

52.Alvero, A.B. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype. / A.B. Alvero [et al.] //Am J Reprod Immunol. 2012. 67(3). .

256-265.

53.Amirzargar, A. Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients / A. Amirzargar [et al.] // Mult Scler. 2007. 13(2). .

253-255.

54.Ang, P. BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy / P. Ang, I. Lim, T. Lee, J. Luo [et al.] // Cancer Epidemiol Biomarkers Prev. 2007. 16. . 2276-2284.

55.Armaou, S. Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases / S. Armaou [et al.] // British Journal of Cancer. 2009. 101. . 32-37.

56.Barbisan, G. TNF- and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk / G. Barbisan, L. Prez, A. Contreras, C. Golijow // Tumour Biol. 2012. 33(5). . 1549-1556.

57.Baudi, F. Evidence of founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer / F. Baudi, B.

Quaresima, C.Grandinetti // Hum Mutat. 2001. 18. . 163-164.

58.Belogianni, I. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer / I. Belogianni [et al.] // BMC Cancer. 2004. 4(61). . 1-8.

59.Bergthorsson, J. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age / J. Bergthorsson [et al.] // J Med Genet. 2001. 38. . 361-368.

60.Bic Database. BRCA1 exon mutations separated by mutation type [ ]. : http://research.nhgri.nih.gov/projects/bic/

61.Bidwell, J. Cytokine gene polymorphism in human disease: on-line databases / J.

Bidwell [et al.] // Genes Immun. 1999. 1(1). . 3-19.

62.Bjorge, T. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study / T. Bjorge [et al.] // British Journal of Cancer. 2004. 91. . 1829-1834.

63.Blay, P. Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain) / P. Blay [et al.] // BMC Cancer. 2013. 13(243). . 1-10.

64.Boca, A.N. Genetic variations in IL6 and IL12B decreasing the risk for psoriasis / Boca A.N. [et al.] // Immunol Lett. 2013. 156(1-2). . 127-131.

65.Breast Cancer, Early Onset [ ]. :

http://www.genecards.org/cgi-bin/carddisp.pl?gene=BRCA1/2/

66.Bright, J. Differential influence of interleukin-12 in the pathogenesis of autoimmune and virus-induced central nervous system demyelination / J. Bright, M. Rjdriguez, S. Sriram // Journal of virology. 1999. 73(2). . 1637-1639.

67.Brozek, I. Prevalence of the most frequent BRCA1 mutations in Polish population / I. Brozek [et al.] // Journal of Applied Genetics. 2011. 52. . 325-330.

68.Callard, R. Immunoregulation by interleukin-4 in man / R. Callard // British Journal of Haematology. 1991. 78(3). . 293-299.

69.Capalbo, C. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models / C. Capalbo [et al.] // Annals of Oncology. 2006. 17(7).

. 1-7.

70.Chen, J. Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients / J. Chen [et al.] // Int J Biol Sci. 2011. 7(1). .

53-60.

71.Chen, S. Emerging role of IL-17 in atherosclerosis / S. Chen, T.R. Crother, M.

Arditi // J Innate Immun. 2010. 2(4). . 325-333.

72.Chen, T. Association of single nucleotide polymorphisms in interleukin 12 (ILA and -B) with asthma in a Chinese population / Chen T. [et al.] // Hum Immunol. 2011. 72(7). . 603-606.

73.Chen, X. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women / X. Chen [et al.] // Clin Cancer Res. 2009. 15(1). . 400-405.

74.Chu, H. The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study / H. Chu [et al.] // Mol Biol Rep.

2012. 39(5). . 5349-5357.

75.Claes, K. BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families / K. Claes [et al.] // British Journal of Cancer. 2004. 90. . 1244-1251.

76.Cybulski, C. BRCA1 mutations and prostate cancer in Poland / C. Cybulski [et al.] // Eur J Cancer Prev. 2008. 17(1). . 62-66.

77.Daneshmandi, S. Cytokine gene polymorphism and asthma susceptibility, progress and control level / S. Daneshmandi [et al.] // Mol Biol Rep. 2012. 39(2). . 1845-1853.

78.Diez, . Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients / O. Diez [et al.] // British Journal of Cancer. 1999. 79(7/8).

. 1302-1303.

79.Ding, R. Effect of interleukin-2 level and genetic variants on coronary artery disease / R. Ding [et al.] // Inflammation. 2013. 36(6). . 1225-1231.

80.Dobrzanski, M.J. Immunotherapy with IL-10- and IFN- -producing CD4 effector

cells modulate Natural and Inducible CD4 TReg cell subpopulation levels:

observations in four cases of patients with ovarian cancer. / M.J. Dobrzanski [et al.] // Cancer Immunol Immunother. 2012. 61(6). . 839-854.

81.Donenberg, T. A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas / T. Donenberg [et al.] // Breast Cancer Res Treat. 2011. 125. . 591-596.

82.Dufloth, R. Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history / R. Dufloth [et al.] // Sao Paulo Med J. 2005. 123(4). . 192-197.

83.Einbeigi, Z. A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer / Z. Einbeigi [et al.] // Eur J Cancer. 2001. 37. . 1904-1909.

84.El-said El-Debaky, F. Breast cancer gene 1 (BRCA 1) mutation in female patients with or without family history in Qalubia governorate / F. El-said El-Debaky [et al.] // Journal of American Science. 2011. - 7(2). . 82-93.

85.El-Omar, E.M. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms / E.M. El-Omar [et al.] // Gastroenterology. 2003. 124(5). . 1193-1201.

86.Erdei, E. Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer / E. Erdei [et al.] // Cytokine. 2010. 51(1). . 18-24.

87.Eskdale, J. Mapping of the human IL10 gene and further characterization of the 5'flanking sequence / J. Eskdale [et al.] // Immunogenetics. 1997. 46. P.120-128.

88.Esteves, V.F. Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil / V.F. Esteves [et al.] // Brazilian Journal of Medical and Biological Research. 2009. 42. .

453-457.

89.Ewald, I.P. Prevalence of the BRCA1 founder mutation c.5266dup in Brazilian individuals at-risk for the Hereditary Breast and Ovarian Cancer Syndrome / I.P.

Ewald [et al.] // Hereditary Cancer in Clinical Practice. 2011. 9 (12). . 1Fedetz, M. Analysis of -631 and -475 interleukin-2 promoter single nucleotide polymorphisms in multiple sclerosis / M. Fedetz [et al.] // Eur J Immunogenet. 2002. 29(5). . 389-390.

91.Ferlazzo, G. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic / G.

Ferlazzo [et al.] // J. Immun. 2004. 172. . 1455-1462.

92.Forones, N.M. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer / N.M. Forones, S.V. Mandowsky, L.G. Loureno // Hepatogastroenterology. 2001. 48(40). . 1199-1201.

93.Gallagher, D. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer / D. Gallagher [et al.] // Clin Cancer Res. 2010. 16(7). .

2115-2121.

94.Georgiou, I. Evaluating cancer risks in BRCA mutation carriers / I. Georgiou [et al.] // Gastric Breast Cancer. 2003. 2(2). . 42-47.

95.Gerger, A. Association of interleukin-10 gene variation with breast cancer prognosis / A. Gerger [et al.] // Breast Cancer Res Treat. 2010. 119. P.

701-705.

96.Gibson, A. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus / A.

Gibson [et al.] // J Immunol. 2001. 166. . 3915-3922.

97.Ginsburg, O.M. Family history, BRCA mutations and breast cancer in Vietnamese women / O.M. Ginsburg [et al.] // Clinical Genetics. 2010. . 1-4.

98.Giordani, L. Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor- genes / L. Giordani [et al.] // Clinical Chemistry. 49 (10). 2003. P.1664-1667.

99.Gomes, M. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4 / M. Gomes [et al.] // Gene. 2012. 504(1). . 111-115.

100. Gonullu, G. Association of breast cancer and cytokine gene polymorphism in Turkish women / G. Gonullu [et al.] // Saudi Med J. 2007. 28(11). P.1728-1733.

101. Gooch, J. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells / J. Gooch, A. Lee, D. Yee // Cancer Research. 1998. 58.

. 4199-4205.

102. Gorski, B. A high proportion of founder BRCA1 mutations in Polish breast cancer families / B. Gorski [et al.] // Int. J. Cancer. 2004. 110. . 683-686.

103. Gronwald, J. Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status / J. Gronwald [et al.] // Journal of Medical Genetics. 2006. 43. . 424-428.

104. Grudinina, N. A. Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St. Petersburg / N.A. Grudinina [et al.] // Russian Journal Of Genetics. 2005. 41(3). . 318-322.

105. Gubler, U. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor / U. Gubler [et al.] // Proc. Nat. Acad. Sci. 1991. - 88. . 4143-4147.

106. Hamann, U. Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany / U. Hamann [et al.] // European Journal of Human Genetics. 2003. 11. . 464-467.

107. Hamidullah. Role of interleukin-10 in breast cancer / Hamidullah, B.

Changkija, R. Konwar // Breast Cancer Res Treat. 2012. 133(1). . 11-21.

108. Han, S. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women / S. Han [et al.] // Eur J Obstet Gynecol Reprod Biol. 2008. 140(1). . 71-75.

109. Han, X. High-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling / X. Han [et al.] // BMC Genomics. 2008. 9(476). . 1-10.

110. Haukim, N. Cytokine gene polymorphism in human disease: on-line databases, supplement 2 / N. Haukim [et al.] // Genes Immun. 2002. 3(6). . 313-330.

111. He, J.-R. Joint effects of Epstein-Barr virus and polymorphisms in Interleukin-10 and Interferon- on breast cancer risk / J.-R. He [et al.] // The Journal of Infectious Diseases. 2012. 205. P. 64-71.

112. Hillman, G.G. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factoralpha (TNF-alpha) on human renal cell carcinoma / G.G. Hillman [et al.] // Clin Exp Immunol. 1994. 96(3). 476-483.

113. Hodges, E. Detection of T-cell receptor beta chain mRNA in frozen and paraffin-embedded biopsy tissue using digoxigenin-labelled oligonucleotide probes in situ / E. Hodges [et al.] // J Pathol. 1994. 174(3). . 151-158.

114. Hoon, D.S. Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells / D.S. Hoon [et al.] // Cancer Immunol Immunother. 1993. 37(6). . 378-384.

115. Howell, W. Cytokine gene polymorphisms, cancer susceptibility, and prognosis / W. Howell [et al.] // J Nutr. 2007. 137(1). P.194S-199S.

116. Hu, X. Interleukin-2 gene polymorphisms and prognosis of breast cancer / X. Hu, L. Ouyang, L. Tang // Genetic Testing and Molecular Biomarkers. 2013.

17(6). . 453-457.

HuGE Literature Finder [ ]. :

117.

http://www.64.29.163.162:8080/HuGENavigator/searchSummary.do?firstQuery= Breast Neoplasms+and+BRCA1&publitSearchType/ 118. Hughes, L. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection / L. Hughes [et al.] // Cancer Epidemiol Biomarkers Prev. 2012. 21(1). .

53-60.

119. Inanir, A. IL-4 and MTHFR gene polymorphism in rheumatoid arthritis

and their effects / A. Inanir [et al.] // Immunol Lett. 2013. 152(2). . 104]. :

120. Interleukin 10 [ http://www.genecards.org/cgi-bin/carddisp.pl?gene= IL10/ 121. Interleukin 12 (Natural Killer Cell Stimulatory Factor 2, Cytotoxic

Lymphocyte Maturation Factor 2, P40) [ ]. :

http://www.genecards.org/cgi-bin/carddisp.pl?gene= IL12/

Interleukin 17 [ ]. :

122.

http://www.genecards.org/cgi-bin/carddisp.pl?gene= IL17/

Interleukin 2 [ ]. :

123.

http://www.genecards.org/cgi-bin/carddisp.pl?gene= IL2/

Interleukin 4 [ ]. :

124.

http://www.genecards.org/cgi-bin/carddisp.pl?gene= IL4/ 125. Iqbal, J. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers / J. Iqbal [et al.] // Br J Cancer. 2012. 107 (12). .

2005-2009.

126. Ivansson, E. Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer / E. Ivansson [et al.] // Int J Cancer. 2007. 121(11). P. 2451-2457.

127. Iyoda, M. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF- and IL-1 / M. Iyoda [et al.] // Am. J. Physiol. Renal. Physiol. 2010. 3. P. 779-787.

128. Jara, L. BRCA1 and BRCA2 mutations in a South American population / L. Jara [et al.] // Cancer Genetics and Cytogenetics. 2006. 166(1). . 36Jasinska, A. Prevalence of BRCA1 founder mutations in Western Poland / A. Jasinska [et al.] // Human Mutation. 2000. 17(1). . 1-7.

130. John, E. M. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups / E.M. John [et al.] // Journal of the American Medical Association. 2007. 298(24). . 2869-2876.

131. Jong, M. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility / M. de Jong [et al.] // J Med Genet. 2002. 39. P. 225-242.

132. Joshi, N.N. Opposing effects of pro- and anti-inflammatory cytokine gene polymorphisms on the risk for breast cancer in western Indian women: a pilot study / N.N. Joshi [et al.] // Int J Immunogenet. 2013. doi: 10.1111/iji.12098.

133. Kaarvatn, M. Single nucleotide polymorphism in the Interleukin 12B gene is associated with risk for breast cancer development / M. Kaarvatn [et al.] // Scand J Immunol. 2012. 15. . 1365-1383.

134. Kadouri, L. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations / L. Kadouri [et al.] // J Med Genet. 2007. 44. . 467-471.

135. Kamangar, F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world / F. Kamangar, G. Dores, W. Anderson // J Clin Oncol. 2006. 24(14). . 2137-2150.

136. Kang, E. The Korean hereditary breast cancer study: review and future perspectives / E. Kang, S. Kim // J Breast Cancer. 2013. 16(3). . 245Khoo, U. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations / U. Khoo, H. Ngan, A.

Cheung, K. Chan // Human Mutation. 2000. 337. . 1-5.

138. Khoo, U. Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population / U.

Khoo [et al.] // Human Mutation. 2002. 19(3). . 307-308.

139. Kingo, K. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility / K. Kingo [et al.] // J Dermatol Sci. 2005. 37(2). P. 111-113.

140. Kong, F. Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population / F. Kong [et al.] // Journal of Experimental & Clinical Cancer Research. 2010. 29(72). P. 1-7.

141. Konwar, R. Breast cancer risk associated with polymorphisms of IL-1RN and IL-4 gene in Indian women / R. Konwar [et al.] // Oncology Research. 2009.

17(8). . 367-372.

142. Korde, L.A. No evidence of excess breast cancer risk among mutationnegative women from BRCA mutation-positive families / L.A. Korde [et al.] // Breast Cancer Research and Treatment. 2011. 125. . 169-173.

143. Koumpis, C. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece / C. Koumpis [et al.] // Hereditary Cancer in Clinical Practice. 2011. 9 (10). . 1-4.

144. Kozowski, L. Concentration of interleukin-6 (IL-6),interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients / L.

Kozowski, I. Zakrzewska, P. Tokajuk, M. Wojtukiewicz // Roczniki Akademii Medycznej w Bialymstoku. 2003. 48. . 82-84.

145. Krajc, M. BRCA2 founder mutation in Slovenian breast cancer families / M. Krajc [et al.] // European Journal of Human Genetics. 2002. 10. .

879-882.

146. Krajc, M. Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families / M. Krajc [et al.] // BMC Medical Genetics. 2008. 9(83). . 1-8.

147. Krylova, N.Y. BRCA1 4153delA founder mutation in Russian ovarian cancer patients / N.Y. Krylova [et al.] // Hereditary Cancer in Clinical Practice. 2006. 4(4). . 193-196.

148. Kuhn, D. The role of interleukin-2 receptor alpha in cancer / D. Kuhn, Q.

Dou // Front Biosci. 2005. 10. . 1462-1474.

149. Kwon, E.M. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk / E.M. Kwon [et al.] // Cancer Epidemiol Biomarkers Prev. 2011. 20(5). . 923-933.

150. Kwong, A. Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis / . Kwong [et al.] // PLoS One. 2012. 7(9). . 1Langsenlehner, U. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk / U. Langsenlehner [et al.] // Breast Cancer Res Treat. 2005. 90(2). P.113-115.

152. Lavie, O. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population / O. Lavie [et al.] // Annals of Oncology. 2010. 5. . 1Leland, P. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-pseudomonas exotoxin fusion protein in vitro and in vivo / P. Leland [et al.] // Molecular Medicine. 2000. 6(3). . 165-178.

154. Levy-Lahad, E. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breastovarian cancer families/ E. Levy-Lahad [et al.] // Am J Hum Genet. 1997. 60. . 1059-1067.

155. Li, X. Interleukin-4 -590T/C polymorphism influences the susceptibility to nonsmall cell lung cancer / X. Li [et al.] // DNA Cell Biol. 2012. 31(5). .

797-800.

156. Liang, W. Association study of bronchial asthma with polymorphisms of IL-4 and IL-4R receptor genes / W. Liang [et al.] // Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014. 31(1). . 97-100.

157. Liede, A. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan / A. Liede [et al.] // Am J Hum Genet. 2002. 71.

. 595-606.

158. Litjens, N.H. Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism / N.H. Litjens [et al.] // J Invest Dermatol. 2004. 122(4). . 923-926.

159. Loureno, J. BRCA1 mutations in Brazilian patients / J. Loureno [et al.] // Genetics and Molecular Biology. 2004. 27(4). . 500-504.

160. Lucas, A.L. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts / A.L. Lucas [et al.] // Cancer. 2014. 120 (13). . 1960-1967.

161. Lyon, D. Cytokine comparisons between women with breast cancer and women with a negative breast biopsy / D. Lyon, N. McCain, J. Walter // Nurs Res.

2008. 57(1). . 51-58.

162. Mahfoudh, W. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population / W. Mahfoudh [et al.] // Molecular Biology Reports. 2012. 39. . 1037-1046.

163. Mai, P. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma / P. Mai [et al.] // PLoS One. 2009. 4(3). . 1-10.

164. Malek, T.R. Interleukin-2 receptor signaling: at the interface between tolerance and immunity / T. R. Malek, I. Castro // Immunity. 2010. 33(2). . 153-165.

165. Manguoglu, E. Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancerpatients / E. Manguoglu [et al.] // Cancer Genet Cytogenet. 2010. 203(2). . 230-237.

166. Mann, G. J. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource / G. J. Mann [et al.] // Breast Cancer Research. 2006. 8. . 1-15.

167. Martin-Orozco, N. Th17 cells promote cytotoxic T-cell activation in tumor immunity / N. Martin-Orozco [et al.] // Immunity. 2009. 31(5). . 787Martnez-Ferrandis, J. Mutational analysis of BRCA1 and BRCA2 in mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations / J. Martnez-Ferrandis [et al.] // Human Mutation. 2003. 659. . 1-5.

169. Matesanz, F. Allelic expression and interleukin-2 polymorphisms in multiple sclerosis / F. Matesanz [et al.] // J Neuroimmunol. 2001. 119(1). . 101-105.

170. Matsumoto, K. Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women / K. Matsumoto [et al.] // Japan J of Clin Oncol. 2010. 40(11). P.1113-1116.

171. Mehdipour, P. Low frequency of 185delAG founder mutation of BRCA1 gene in Iranian breast cancer patients / P. Mehdipour [et al.] // Journal of Cancer Molecules. 2006. 2 (3). . 123-127.

172. Merendino, R. Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients / R. Merendino [et al.] // Immunol Lett. 1999. 68(2-3). . 355-358.

173. Miki, Y. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 / Y. Miki [et al.] // Science. 1994. 266(5182). . 66-71.

174. Miron, A. Testing for hereditary breast and ovarian cancer in the Southeastern United States / A. Miron [et al.] // Annals of Surgery. 2000. 231 (5). . 624-634.

175. Miteva, L. Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer / L.

Miteva [et al.] // Cancer Invest. 2009. 27(9). . 924-931.

176. Mocellin, S. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle / S. Mocellin [et al.] // Cytokine Growth Factor Rev. 2004. Vol.15. P.61-76.

177. Moon, C.M. Genetic variants in the IL12B gene are associated with inflammatory bowel diseases in the Korean population / C.M. Moon [et al.] //J Gastroenterol Hepatol. 2013. 28(10). . 1588-1594.

178. Morahan, G. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children / G. Morahan [et al.] // Lancet. 2002.

360(9331). . 455-459.

179. Moreno, O. Polymorphisms in the IL4 and IL4RA genes in Colombian patients with rheumatoid arthritis / O. Moreno [et al.] // J Rheumatol. 2007. 34(1). . 36-42.

180. Morga, E. Interleukin-4 down-regulates MHC class II antigens on cultured rat astrocytes / E. Morga, P. Heuschling // Glia. 1996. 17 (2). . 175-179.

181. Morgan, D. A. Selective in vitro growth of T lymphocytes from normal human bone marrows / D.A. Morgan, F.W. Ruscetti, R. C. Gallo // Science. 1976. 193 (4257). . 1007-1008.

182. Morris, G.A. Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and Argentina / G.A. Morris [et al.] // PLoS One. 2011. 6(2). . 1-10.

183. Motoyama, S. Interleukin-2 -330TG genetic polymorphism associates with prognosis following surgery for thoracic esophageal squamous cell cancer / S. Motoyama [et al.] // Ann Surg Oncol. 2011. 18(7). . 1995-2002.

184. Movahedi, M. IL-10, TGF-beta, IL-2, IL-12 and IFN-gamma cytokine gene polymorphisms in asthma / M. Movahedi [et al.] // J Asthma. 2008. 45(9). . 790-794.

185. Nagai, S. Interleukin-4 and breast cancer / S. Nagai, M. Toi // Breast Cancer. 2000. 7(3). . 181-186.

186. Nanda, R. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry / R. Nanda [et al.] // Journal of the American Medical Association. 2005. 15. . 1925-1933.

187. Nathanson, K. Breast cancer genetics: what we know and what we need / K. Nathanson, Wooster R., Weber B. // Nat. Med. 2001. 7. . 552-556.

188. Negur, L. Identification of a recurrent BRCA1 mutation in two breast/ovarian cancer predisposition families with distinct phenotypes, by using allele-specific multiplex-PCR / L. Negur [et al.] // Revista Romana de Medicina de Laborator. 2010. 18(2/4). . 53-61.

189. Neuhausen, S. L. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study / S. L.

Neuhausen [et al.] // American Journal of Human Genetics. 1998. 62. .

1381-1388.

190. Neuhausen, S. L. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study / S.L.

Neuhausen [et al.] // American Journal of Human Genetics. 1996. 58. .

271-280.

191. Numasaki, M. Interleukin-17 promotes angiogenesis and tumor growth / M. Numasaki, J. Fukushi, M. Ono [et al.] // Blood. 2003. 101(7). . 2620Olopade, O. I. Breast cancer genetics in African Americans / O. I. Olopade [et al.] // Cancer. 2003. 1(97). . 236-245.

193. Onay, V. SNP-SNP interactions in breast cancer susceptibility / V. Onay [et al.] // BMC Cancer. 2006. 6(114). .1-16.

194. Oppenheim, J. IL-2: more than a T cell growth factor / J. Oppenheim // J Immunol. 2007. 179. . 1413-1414.

195. Osorio, A. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer / A. Osorio [et al.] // Int. J.

Cancer. 2002. 99. . 305-309.

196. Palmieri, G. BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling / G. Palmieri [et al.] // Annals of Oncology. 2002. 13. . 1899-1907.

197. Palomba, G. A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population / G. Palomba [et al.] // BMC Cancer. 2009. 9(245). . 1-10.

198. Paradowska-Gorycka, A. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA) / A. ParadowskaGorycka [et al.] // Scandinavian Journal of Immunology. 2010. 72. .134Paul, W. Interleukin-4: a prototypic immunoregulatory lymphokine / W.

Paul // Blood. 1991. 77(9). . 1859-1870.

200. Paunovic, V. Crossed signals: the role of interleukin (IL)-12, -17, -23 and in autoimmunity / V. Paunovic, H.P. Carroll, K.Vandenbroeck, M. Gadina // Rheumatology. 2008. 47. . 771-776.

201. Peelen, T. Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families / T. Peelen [et al.] // British Journal of Cancer. 2000. 82(1).

. 151-156.

202. Phelan, C. A Low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families/ C. Phelan [et al.] // Human Mutation. 2002. 20. . 352-7.

203. Pisano, M. Identification of a founder BRCA2 mutation in Sardinia / M.

Pisano [et al.] // British Journal of Cancer. 2000. 82(3). . 553-559.

204. Plakhins, G. Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia / G. Plakhins [et al.] // BMC Medical Genetics. 2011. 12(147). . 1-8.

205. Pohlreich, P. High proportion of recurrent germline mutations in the BRCA1gene in breast and ovarian cancer patients from the Prague area / P.

Pohlreich [et al.] // Breast Cancer Research. 2005. 7(5). . 728-736.

206. Pooja, S. Polymorphic variations in IL-1, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women / S. Pooja [et al.] // Cytokine. 2012. 60(1). . 122-128.

207. Portielje, J. IL-12: a promising adjuvant for cancer vaccination / J. Portielje [et al.] // Cancer Immunol. Immunother. 2003. 52. P. 133-144.

208. Purnomosari, D. BRCA1 and BRCA2 germline mutation analysis in the Indonesian population / D. Purnomosari [et al.] // Breast Cancer Res Treat. 2007. 106. . 297-304.

209. Qian, F. Association between polymorphisms in IL17F and male asthma in a Chinese population / F. Qian [et al.] // Journal of Investigational Allergology and Clinical Immunology. 2012. 22. . 257-263.

210. Quan, Y. Association between IL17 polymorphisms and risk of cervical cancer in Chinese women / Y.Quan [et al.] // Clinical and Developmental Immunology. 2012. . 1-6.

211. Randolph, A.G. The IL12B gene is associated with asthma / A.G.

Randolph [et al.] // Am J Hum Genet. 2004. 75(4). . 709-715.

212. Rao, V. Potential prognostic and therapeutic roles for cytokines in breast cancer (Review) / V. Rao [et al.] // Oncology Reports. 2006. 15. . 179Rao, V. IL-10 and IL-12 expression in breast cancer patients and effect of therapy / V. Rao [et al.] // Journal of Clinical Oncology. 2008. 26(15S). . 140-146.

214. Roa, B.B. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 / B.B. Roa [et al.] // Nat Genet. 1996. 14(2). .

185-187.

215. Robles-Daz, L. Hereditary ovarian cancer in Ashkenazi Jews / L. RoblesDaz [et al.] // Fam Cancer. 2004. - 3(3-4). . 259-264.

216. Roh, J. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women / J. Roh [et al.] // Cancer Lett. 2002. 184(1). . 57-63.

217. Rosenberg, S.A. Progress in human immunology and immunotherapy / S.A. Rosenberg // Nature. 2001. 411. P. 380-384.

218. Roszak, A. Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer / A. Roszak [et al.] // Pathol Oncol Res. 2012. 18(4). .

997-1002.

219. Sarantaus, L. BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients / L. Sarantaus [et al.] // European Journal of Human Genetics. 2001. 9. . 424-430.

220. Saxena, S. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India / S. Saxena [et al.] // BMC Medical Genetics. 2006. 7(75). . 1-12.

221. Sayad, A. The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients / A. Sayad [et al.] // Cell J. 2013. 15(2). . 124-129.

222. Scarel-Caminaga, R.M. Frequencies of the -330 (T G) IL-2 and -590 (T

C) IL-4 gene polymorphisms in a population from south-eastern Brazil / R.M.

Scarel-Caminaga [et al.] // Eur J Immunogenet. 2002. 29(4). . 293-296.

223. Selvaraj, P. Cytokine gene polymorphisms and cytokine levels in pulmonary tuberculosis / P. Selvaraj [et al.] // Cytokine. 2008. 43(1). .

26-33.

224. Sermijn, E. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation / E. Sermijn [et al.] // J Med Genet. 2004. 41. . 1-7.

225. Shahbazi, M. High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis / M. Shahbazi [et al.] // Clin Immunol. 2010. 137(1). . 134-138.

226. Shen, Y.The association between -330T/G polymorphism of interleukin 2 gene and bladder cancer / Y. Shen, Y. Liu, S. Liu, A. Zhang //DNA Cell Biol. 2012. 31(6). . 983-987.

227. Shibata, T. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis / T.Shibata [et al.] // Hum Immunol. 2009. 70(7). . 547-551.

228. Shin, W.G. Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea / W.G. Shin [et al.] // J Gastroenterol Hepatol. 2008. 23(10). . 1567-1573.

229. Sima, X. Gene-gene interactions between interleukin-12A and interleukinB with the risk of brain tumor / X. Sima [et al.] // DNA Cell Biol. 2012. 31(2). . 219-223.

230. Singh, H. Association of TNFA (-308GA) and IL-10 (-819CT) promoter polymorphisms with risk of cervical cancer / H. Singh [et al.] // Int J Gynecol Cancer. 2009. 19(7). P. 1190-1194.

231. Slater, E. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families / E. Slater [et al.] // Fam Cancer. 2010. 9(3). . 335-343.

232. Smith, K. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis / K. Smith, A. Bateman, H. Fussell, W. Howell // Eur J Immunogenet. 2004. 31(4). . 167-173.

233. Smyth, M. Cytokines in cancer immunity and immunotherapy / M. Smyth [et al.] // Immunol Rev. 2004. 202. P. 275-293.

234. Soegaard, M. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark / M. Soegaard [et al.] // Clinical Cancer Research. 2008. 14. . 3761Son, B. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study / B. Son [et al.] // Breast Cancer Res Treat. 2012. 133. . 1143-1152.

236. Song, H. Interleukin 2 gene polymorphisms are associated with nonHodgkin lymphoma / H. Song, L. Chen, Z. Cha, J. Bai // DNA Cell Biol. 2012.

31(7). . 1279-1284.

237. Soumittra, N. Molecular genetics analysis of hereditary breast and ovarian cancer patients in India / N. Soumittra [et al.] // Hereditary Cancer in Clinical Practice. 2009. 7(13). . 1-10.

238. Southey, M.C. BRCA1 mutations and other sequence variants in a population based sample of Australian women with breast cancer/ M.C.Southey [et al.] // British Journal of Cancer. 1999. 79(1). . 34-39.

239. Souza, J. IL-17 and IL-22 serum cytokine levels in patients with squamous intraepithelial lesion and invasive cervical carcinoma / J. Souza [et al.] // Eur J Gynaecol Oncol. 2013. 34(5). . 466-468.

240. Stanczuk, G. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production / G. Stanczuk [et al.] // Int. J. Cancer. 2001. 94. . 792-794.

241. Struewing, J. P. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews/ J. P. Struewing [et al.] // The New England Journal of Medicine. 1997. 20. . 1401-1408.

242. Sugano, K. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer / K. Sugano [et al.] // Cancer Scince. 2008. 99(10). . 1967-1976.

243. Sugimoto, M. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer / M. Sugimoto, Y. Yamaoka, T. Furuta // World J Gastroenterol. 2010. 16(10). . 1188-1200.

244. Suter, N. BRCA1 and BRCA2 mutations in women from Shanghai China / N. Suter [et al.] // Cancer Epidemiology Biomarkers & Prevention. 2004. 13(2). . 181-189.

245. Tamboom, K. BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia / K. Tamboom [et al.] // Hereditary Cancer in Clinical Practice. 2010. 8(4). . 1-7.

246. Tao, Y.P. Associations between polymorphisms in IL-12A, IL-12B, ILR1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer / Y.P. Tao [et al.] // J Cancer Res Clin Oncol. 2012. 138(11). .

1891-1900.

247. Tamandani, D.M. Interleukin-12 gene polymorphism and cervical cancer risk / D.M. Tamandani, M. Shekari, V. Suri // Am J Clin Oncol. 2009. 32(5). . 524-528.

248. Tavtigian, S. V. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds / S. V. Tavtigian [et al.] // Nature Genet. 1996. 12. .

333-337.

249. Tesarova, P. Soluble TNF and IL-2 receptors in patients with breast cancer / P. Tesarova [et al.] // Med Sci Monit. 2000. 6(4). . 661-667.

250. Tindall, E.A. The 4q27 locus and prostate cancer risk / E.A. Tindall [et al.] // BMC Cancer. 2010. 10(69). . 1-6.

TNM. Classification of malignant tumours [ ]. 251.

: http://www.uicc.org/resources/tnm/

252. Turner, D. An investigation of polymorphism in the interleukin-10 gene promoter / D.Turner [et al.] // Eur J Immunogenet. 1997. 24. P.1-8.

253. Uglanitsa, N. The contribution of founder mutations in BRCA1 to breast cancer in Belarus / N. Uglanitsa [et al.] // Clin Genet. 2010. 78. . 377Vaidyanathan, K. BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identifi cation of four novel mutations and highfrequency occurrence of 185delAG mutation / K. Vaidyanathan [et al.] // J Biosci.

2009. 34(3). . 415-422.

255. Vehmanen, P. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes / P.

Vehmanen [et al.] // Human Molecular Genetics. 1997. 6(13). . 2309Venkitaraman, . Functions of BRCA1 and BRCA2 in the biological 256.

response to DNA damage / . Venkitaraman // Journal of Cell Science. 2001. 114. . 3591-3598.

257. Vinodkumar, B. Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families / B.Vinodkumar [et al.] // Cancer Biology & Therapy. 2002. 1(1). . 18-21.

258. Vinodkumar, B. Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India / B.Vinodkumar [et al.] // J Exp Clin Cancer Res. 2007. 26(3). . 329-336.

259. Waldmann, T. The IL-2/IL-2 receptor system: a target for rational immune intervention / T. Waldmann // Immunology Today. 1993. 14. . 264-270.

260. Walsh, T. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer / T. Walsh [et al.] // Journal of the American Medical Association. 2006. 295(12). . 1379-1388.

261. Wang, J. Association of genetic polymorphisms in the IL12-IFNG pathway with susceptibility to and prognosis of pulmonary tuberculosis in a Chinese population / J. Wang, S. Tang, H. Shen // Eur J Clin Microbiol Infect Dis. 2010.

29(10). . 1291-1295.

Wang, L. Association analysis of IL-17A and IL-17F olymorphisms in 262.

Chinese Han women with breast cancer / L.Wang [et al.] // www.plosone.org. 2012. . 1-7.

263. Wang, Q. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population / Q. Wang [et al.] // Eur J Obstet Gynecol Reprod Biol. 2011. 158(2). P. 330-333.

264. Wang, Y. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures / Y.Wang [et al.] // Genes Dev. 2000. 14(8). . 927-939.

265. Wei, Y. Association of the interleukin-2 polymorphisms with interleukin-2 serum levels and risk of nasopharyngeal carcinoma / Y. Wei, Y. Lan, L. Zhang, J.

Wang // DNA and Cell Biology. 2010. 29(7). . 363-368.

266. Weitzel, J.N. Prevalence of BRCA mutations and founder effect in highrisk Hispanic families / J.N. Weitzel [et al.] // Cancer Epidemiology, Biomarkers & Prevention. 2005. 14. . 1666-1671.

267. Wooster, R. Identification of the breast cancer susceptibility gene BRCA2 / R. Wooster [et al.] // Nature. 1995. 378. . 789-792.

268. Wu, J. Promoter polymorphisms of IL-2, IL-4, and risk of gastric cancer in a high-risk Chinese population / J. Wu [et al.] // Mol Carcinog. 2009. 48(7).

. 626-632.

269. Wu, X. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer / X.Wu [et al.] // International Journal of Cancer. 2010. 127. . 86-92.

270. Xu, Z. A functional variant in IL12B promoter modulates its expression and associates with increased risk of allergic asthma / Z. Xu [et al.] // Genes Immun. 2013. 14(4). . 238-243.

271. Yang, X.X. Association of TGF-beta1, IL-4 and IL-13 gene polymerphisms with asthma in a Chinese population / X.X. Yang [et al.] // Asian Pac J Allergy Immunol. 2011. 29(3). . 273-277.

272. Yannopoulos, A. The (590 C/T) polymorphism in the Interleukin-4 gene is associated with increased risk for early stages of corolectal adenocarcinoma / A.

Yannopoulos, N. Nikiteas, A. Chatzitheofylaktou, C. Tsigris // In Vivo. 2007. 21. . 1031-1036.

273. Yassaee, V. Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer / V. Yassaee [et al.] // Breast Cancer Res. 2002. 4(4). . 1-6.

274. Zakhartseva, L.M. Breast cancer immunohistochemical features in young women with BRCA1/2 mutations / L.M. Zakhartseva [et al.] // Experimental Oncology. 2009. 31. . 174-178.

275. Zhang, X. Interleukin-17A gene variants and risk of coronary artery disease: a large angiography-based study / X.Zhang [et al.] // Clinica Chimica Acta. 2011. 412. . 327-331.

276. Zhao, B. A novel functional polymorphism, 16974 A/C, in the interleukinuntranslated region is associated with risk of glioma / B. Zhao [et al.] // DNA Cell Biol. 2009. 28(7). . 335-341.



Pages:     | 1 |   ...   | 2 | 3 || 5 |
 

:

- - - 06.02.03 , , . 2015 . ...

03.02.08 ( ) : ...

ROSA L. 03.02.01 ..., 1. ROSA L. . 2. ROSA L. 2.1. Rosa L. 2.2. Rosa L. 3....

06.02.03 : , ...

. 14.02.02 : , , 20 ...

03.02.03 03.01.06 ( ) ...

- 03.02.03 ...

: 03.02.08 () : , .. 1. ...

13.00.01 , : , ,...

5N 03.02.02 ..., . . 20 1. 2. 2.1. 2.2. 2.3. ...

13.00.01 , ...

˨ (COLUBRIDAE) : , , 03.02.08 () ( ) : , .. 2015 1. ...

, 03.02.08 : ...

- - 06.01.05. : ...

- 03.02.02 : , 2015 1 2 2.1 ...

14.02.01 : , ...

03.02.07 06.01.05 ...

(OVIBOS MOSCHATUS ZIMMERMANN, 1780) 03.02.08 : . . ., . . 2015 .. 1. -...

- 14.01.07 ...

- 25.00.25 : ...







 
<<     |    
2016 www.konf.x-pdf.ru - - , ,

, .
, , , , 1-2 .